MORF-440

LY4292009 · Morphic Therapeutic, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MORF-440, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1, First-in-human Study of MORF-440 (LY4292009) in Healthy Participants [Phase 1]